← Back to Search

Behavioural Intervention

Smartphone CBT for Psoriasis and Depression

N/A
Recruiting
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current depression symptoms, defined as a PHQ-9 score of 5 or greater
Dermatologist confirmed diagnosis of psoriasis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 8
Awards & highlights
No Placebo-Only Group

Summary

This trial is a small study where participants will be enrolled in an 8-week program using a smartphone app and will be guided by a coach. The program will last for 9 weeks, including a

Who is the study for?
This trial is for adults with psoriasis who also have symptoms of depression. Participants should be comfortable using a smartphone and willing to engage in an 8-week CBT program guided by a coach, followed by a follow-up interview.
What is being tested?
The study is testing the effectiveness of an 8-week cognitive behavioral therapy (CBT) program delivered through a smartphone app, which includes guidance from a coach. All participants will receive this intervention.
What are the potential side effects?
Since this is not a drug trial but rather involves psychological therapy via an app, typical medication side effects are not expected. However, some may experience discomfort or emotional distress when confronting personal issues during CBT.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently experiencing symptoms of depression.
Select...
A dermatologist has diagnosed me with psoriasis.
Select...
I currently have mild psoriasis symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 8 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Client Satisfaction Questionnaire-8 (CSQ-8)
Participants Engagement
Patient Health Questionaire-9 (PHQ-9)
Secondary study objectives
Appearance Anxiety Inventory (AAI)
Frequency of participants with adverse events
Psoriasis Symptom Inventory
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Coach-guided smartphone delivered CBT programExperimental Treatment1 Intervention
All eligible participants will be enrolled in an 8-week coach-guided smartphone delivered CBT program. The full duration of the program, with follow-up interview, will be 9 weeks.

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,666 Previous Clinical Trials
11,840,205 Total Patients Enrolled
4 Trials studying Psoriasis
1,138 Patients Enrolled for Psoriasis
National Psoriasis FoundationOTHER
11 Previous Clinical Trials
1,852 Total Patients Enrolled
10 Trials studying Psoriasis
1,830 Patients Enrolled for Psoriasis
~16 spots leftby Oct 2025